Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
Bronx Times-Reporter20h
Gibson announces new investment to combat opioid use in the HUB
Bronx officials, nonprofits and community organizations came together Thursday to celebrate new investments in treating the opioid crisis plaguing the South ...
Bavarian Nordic A/S: Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
The Canadian Press on MSN19h
Flu cases continue to rise across Canada, public health agency data shows
Flu cases are continuing to rise across the country, public health data shows, with Quebec, B.C. and the territories ...
ophthalmologytimes6h
MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...